ESG

As RNA therapies boom, a new enzymatic platform promises to solve critical manufacturing bottlenecks, making next-gen drugs more scalable and sustainable.

Chinese robotics firm KaiTu Technology debuts its AI-powered forklifts and AMRs in Silicon Valley, signaling a new era of global competition in automation.

Microban’s new EcoFresh odor control gets the USDA Certified Biobased label, signaling a major shift toward sustainable, high-performance textiles.

Investment firm Malar Group backs wellness startup Attaboy Labs, betting on clinical science over marketing hype in the booming supplement industry.

Taiwanese foundry UMC posts a 108% profit surge, driven by strong 22nm chip demand, a key Intel partnership, and a positive outlook despite global risks.

The hardware maker's strategic shift to high-value parts for AI and EVs results in a stunning 177% profit surge, signaling a new era of global growth.

DJI's new report reveals agricultural drones cut 51Mt in carbon emissions and saved 410Mt of water, marking a major shift in global food production.

Berlin-based Tacalyx is advancing its lead drug, TCX-201, to the clinic, targeting a novel class of antigens once thought impossible to drug.

A new provider launches personalized ABA therapy in Colorado homes, addressing service gaps for children with autism with plans for a future clinic.

At SynBioBeta 2026, Ansa Biotechnologies unveils a bold on-time guarantee, challenging rivals and promising to accelerate research with its advanced DNA tech.

A new stem cell therapy promises a one-time cure for hemophilia A, and the FDA is clearing the path. Could lifelong, costly infusions become a memory?

The RTD giant is launching its first limited-edition flavor, Transfusion, using a streetwear-style 'drop' to tap into the booming golf lifestyle market.

Student entrepreneurs from 15 countries converge in San Diego to pitch world-changing ideas, from pineapple-fiber hair ties to crypto for Gen Z.

Beloved SF institution Bi-Rite Market announces a new Richmond District store, promising to revitalize a historic site and deepen its community-first mission.

Oral care leader quip and skincare giant Glowbar partner, signaling a major shift toward simplified, habit-driven wellness. What does this mean for you?

Once a hospital disinfectant, hypochlorous acid is now a skincare star. Magic Molecule's massive CVS launch signals a major shift in the beauty industry.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

A new Georgia development is trading fairways for farm-to-table living, centering an entire community around food. But can this model redefine luxury?

A new partnership aims to expand a proven trenchless technology, promising to fix aging gas pipes faster, cheaper, and with far less disruption.